NCT/Study#
N/A /
VENETOCLAX-VEN-HMA
Genotypic signatures of response to Venetoclax and Hypomethylating agent in treatment naive Acute Myeloid Leukemia and Myelodysplastic Syndrome
DISEASE GROUP:
Leukemia
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
